Mehl AM - Search Results

1

Characterization of a CD40-dominant inhibitory receptor mutant.

Mehl AM, Jones M, Rowe M, Brennan P. Mehl AM, et al. J Immunol. 2001 Dec 1;167(11):6388-93. doi: 10.4049/jimmunol.167.11.6388. J Immunol. 2001. PMID: 11714804

2

Mechanism of action of a novel latent membrane protein-1 dominant negative.

Brennan P, Floettmann JE, Mehl A, Jones M, Rowe M. Brennan P, et al. J Biol Chem. 2001 Jan 12;276(2):1195-203. doi: 10.1074/jbc.M005461200. J Biol Chem. 2001. PMID: 11031256 Free article.

3

Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.

Mehl AM, Floettmann JE, Jones M, Brennan P, Rowe M. Mehl AM, et al. J Biol Chem. 2001 Jan 12;276(2):984-92. doi: 10.1074/jbc.M003758200. J Biol Chem. 2001. PMID: 11034993 Free article.

4

Phosphatidylinositol 3-kinase is essential for the proliferation of lymphoblastoid cells.

Brennan P, Mehl AM, Jones M, Rowe M. Brennan P, et al. Among authors: mehl am. Oncogene. 2002 Feb 14;21(8):1263-71. doi: 10.1038/sj.onc.1205182. Oncogene. 2002. PMID: 11850846

5

Antibodies for detecting EBV latent proteins.

Rowe M, Mehl A. Rowe M, et al. Methods Mol Biol. 2001;174:219-27. doi: 10.1385/1-59259-227-9:219. Methods Mol Biol. 2001. PMID: 11357648 No abstract available.

6

Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.

Fielding CA, Sandvej K, Mehl A, Brennan P, Jones M, Rowe M. Fielding CA, et al. J Virol. 2001 Oct;75(19):9129-41. doi: 10.1128/JVI.75.19.9129-9141.2001. J Virol. 2001. PMID: 11533177 Free PMC article.

7

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

D'Souza BN, Edelstein LC, Pegman PM, Smith SM, Loughran ST, Clarke A, Mehl A, Rowe M, Gélinas C, Walls D. D'Souza BN, et al. J Virol. 2004 Feb;78(4):1800-16. doi: 10.1128/jvi.78.4.1800-1816.2004. J Virol. 2004. PMID: 14747545 Free PMC article.

8

CD99 expression is positively regulated by Sp1 and is negatively regulated by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.

Lee I, Kim MK, Choi EY, Mehl A, Jung KC, Gil MC, Rowe M, Park SH. Lee I, et al. Blood. 2001 Jun 1;97(11):3596-604. doi: 10.1182/blood.v97.11.3596. Blood. 2001. PMID: 11369656 Free article.

9

Isolation and analysis of two strongly transforming isoforms of the Epstein-Barr-Virus(EBV)-encoded latent membrane protein-1 (LMP1) from a single Hodgkin's lymphoma.

Mehl AM, Fischer N, Rowe M, Hartmann F, Daus H, Trümper L, Pfreundschuh M, Müller-Lantzsch N, Grässer FA. Mehl AM, et al. Int J Cancer. 1998 Apr 13;76(2):194-200. doi: 10.1002/(sici)1097-0215(19980413)76:2<194::aid-ijc5>3.0.co;2-s. Int J Cancer. 1998. PMID: 9537580

10

Human cytomegalovirus inhibits maturation and impairs function of monocyte-derived dendritic cells.

Moutaftsi M, Mehl AM, Borysiewicz LK, Tabi Z. Moutaftsi M, et al. Among authors: mehl am. Blood. 2002 Apr 15;99(8):2913-21. doi: 10.1182/blood.v99.8.2913. Blood. 2002. PMID: 11929782 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

10 results

Search Page

Filters